A short BusinessWorld Online item on Ozempic, the diabetes medication many people now take to lose weight. Few details are available beyond the title.
Recap by typeshit. Full story at BusinessWorld Online.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Longevity Technology reports BodySpec's new offering targets GLP-1 users worried about muscle, with body scans said to take about 12 minutes.
3:21
A short upload with no description, so the reasoning behind the claim isn't given. Worth a tap only if you follow the gray market retatrutide talk.
The dermatologist says many of her patients take GLP-1s, and calls her own weight loss on Zepbound, which she nicknames vitamin Z, life-changing.
Dador looks at how one peptide treatment is being used in dental care for oral health. The clip is short on names and details.
The account credits the FDA with the claim and says it uses retatrutide prescribed in Costa Rica. No FDA statement or details are included.
Loading…